Abstract
Vanadium-containing metallocomplexes are being widely investigated as potential insulin-enhancing or replacement pharmaceutical agents. Experimental evidence of inorganic vanadium’s insulin-mimetic effects, with the immensely appealing feature of oral bioavailability, has prompted design and development of novel organic ligands. Desirable features include low molecular weight, neutral charge, thermodynamic and hydrolytic stability, and a balance between aqueous solubility and lipophilicity. From the initial development of bis(maltolato)oxovanadium(IV), containing the ligand, maltol, which is an approved food additive, to more recent development of metallocomplexes such as imidazoleoxobisperoxovanadate(V), which seek to mimic the active site of vanado-enzymes, such as bromperoxidase, researchers have examined a variety of compounds as solutions to the problems of improved absorption, coupled with minimal toxicity. Also detailed are 5-, 6-, and 7-coordinated compounds, with V-N, V-O, V-S, and temporary complexation, as well as the peroxovanadates currently in development as insulin-mimetic agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lyonnet BM, Martz Martin E (1899) La Presse Medicale 7: 191
Heyliger CE, Tahiliani AG, McNeill JH (1985) Science 227: 1474
Chasteen ND (ed) (1990) Vanadium in biological systems. Kluwer, Dordrecht
Sigel H, Sigel A (eds) (1995) Vanadium and its role in life. Dekker, New York
Srivastava AK, Chiasson J-L (eds) (1995) Vanadium compounds: biochemical and therapeutic applications. Kluwer, Dordrecht (Mol Cell Biochem 153)
Thompson KH, Yuen VG, McNeill JH, Orvig C (1998) Chemical and pharmacological studies of a new class of antidiabetic vanadium complexes. In: Tracey AS, Crans DC (eds) Vanadium compounds. Chemistry, biochemistry, and therapeutic applications. American Chemical Society, Washington, DC, chap 26
Nelson WO, Karpishin TB, Rettig SJ, Orvig C (1988) Inorg Chem 27: 1045
Thompson KH, McNeill JH, Orvig C (1997) Rev Port Quim 4: 3
Shechter Y, Li J, Meyerovitch J, Gefel D, Bruck R, Elberg G, Miller DS, Shisheva A (1995) Mol Cell Biochem 153: 39
Elberg G, He Z, Li J, Sekar N, Shechter Y (1997) Diabetes 46: 1684
Orvig C, Thompson KH, Battell M, McNeill JH (1995) Vanadium compounds as insulin mimics. In: Sigel H, Sigel A (eds) Vanadium and its role in life. Dekker, New York, chap 17
Cohen N, Halberstam M, Shlimovich P, Chang CJ, Shamoon H, Rossetti L (1995) J Clin Invest 95: 2501
Goldfine AB, Simonson DC, Folli F, Patti M-E, Kahn CR (1995) J Clin Endocrinol Metab 80: 3311
Goldfine AB, Willsky G, Kahn CR (1998) Vanadium salts in the treatment of human diabetes mellitus. In: Tracey AS, Crans DC (eds) Vanadium compounds. Chemistry, biochemistry, and therapeutic applications. American Chemical Society, Washington, DC, chap 28
Halberstam M, Cohen N, Shlimovich P, Chang CJ, Shamoon H, Rossetti L (1996) J Clin Invest 45: 659
Setyawati I A, Thompson KH, Sun Y, Lyster DM, Vo C, Yuen VG, Battell M, McNeill JH, Ruth TJ, Zeisler S, Orvig C (1998) J Appl Physiol 84: 569
Reuland DJ, Cao ZX, Rosenhein L, Poehlein S, McCoy L, Turner J, Durham T, Ganguli S (1998) Horm Metab Res 30: 29
Brichard SM, Henquin J-C (1995) Trends Pharmacol Sci 16: 265
Li J, Elberg G, Crans DC, Shechter Y (1996) Biochemistry 35: 8314
Henquin J-C, Brichard SM (1992) La Presse Medicale 21: 1100
Sekar N, Li J, Shechter Y (1996) Crit Rev Biochem Mol Biol 31: 339
Zhang M, Zhou M, Van Etten RL, Stauffacher CV (1997) Biochemistry 36: 15
Bell RH, Jr, Hye RJ (1983) J Surg Res 35: 433
Rakieten N (1963) Cancer Chemother Rep 29: 91
Marliss E (1983) Metab 32 [Suppl 1]: 1
Mordes JP, Rossini AA (1981) Am J Med 70: 353
Penicaud L, Ferre P, Terretaz J, Kinebanyan MF, Leturque A, Dore E, Girard J, Jeanrenaud B, Picon L (1987) Diabetes 36: 626
Curran GL, Azarnoff DL, Bolinger RE (1959) J Clin Invest 38: 1251
Schroeder HA, Balassa JJ, Tipton IH (1963) J Chron Dis 16: 1047
Somerville J, Davies B (1962) Am Heart J 64: 54
Dimond EG, Caravaca J, Benchimol A (1963) Am J Clin Nutr 12: 49
Shechter Y, Karlish SJD (1980) Nature (Lond) 284: 556
Dubyak GR, Kleinzeller A (1980) J Biol Chem 255: 5306
Duckworth WC, Solomon SS, Liepnieks J, Hamel FG, Hand S, Peavy DE (1988) Endocrinology 122: 2285
Degani H, Gochin M, Karlish SJD, Shechter Y (1981) Biochemistry 20: 5795
Amir S, Meyerovitch J, Shechter Y (1987) Brain Res 419: 392
Okumura N, Shimazu TJ (1992) Biochemistry (Tokyo) 112: 107
Hajjar JJ, Dobish MP, Tomicic TK (1989) Proc Soc Exp Biol Med 190: 35
Kellett GL, Barker ED (1989) Biochim Biophys Acta 979: 311
Madsen KL, Porter VM, Fedorak RN (1993) Diabetes 42: 1126
Paquet MR, Romanek RJ, Sargeant RJ (1992) Mol Cell Biochem 109: 149
Mountjoy KG, Flier JS (1990) Endocrinology 127: 2025
Strout HV, Vicario PP, Biswas C, Saperstein R, Brady EJ, Pilch PF, Berger J (1990) Endocrinology 126: 2728
Eriksson JW, Lonnroth P, Smith U (1992) Diabetologia 35: 510
Lonnroth P, Eriksson JW, Posner BI, Smith U (1993) Diabetologia 36: 113
Bruck R, Prigozin H, Krepel Z, Rotenberg P, Shechter Y, Bar-Meir S (1991) Hepatology 14: 540
Roden M, Liener K, Fürnsinn C, Prskavec M, Nowotny P, Steffan I, Vierhapper H, Waldhäusl W (1993) Diabetologia 36: 602
Bosch F,, Arino J, Gomez-Foix A, Giunovart JJ (1987) J Biol Chem 262: 218
Gomez-Foix AM, Rodriguez-Gil JE, Fillat C, Guinovart JJ, Bosch F (1988) Biochem J 255: 507
Rodriguez-Gil JE, Gomez-Foix AM, Fillat C, Bosch F, Guinovart JJ (1991) Diabetes 40: 1355
Rodriguez-Gil JE, Gomez-Foix AM, Arino J, Guinovart JJ, Bosch F (1989) Diabetes 38: 793
Meyerovitch J, Farfel Z, Sack J, Shechter Y (1987) J Biol Chem 262: 6658
Ramanadham S, Cros GH, Mongold JJ, Serrano JJ, McNeill JH (1990) Can J Physiol Pharmacol 68: 486
Pugazhenthi S, Khandelwal RI (1990) Diabetes 39: 821
Venkatesan N, Avidan A, Davidson MB (1991) Diabetes 40: 492
Ramanadham S, Brownsey RW, Cros GH, Mongold JJ, McNeill JH (1989) Metabolism 38: 1022
Meyerovitch J, Shechter Y, Amir S (1989) Physiol Behavior 45: 1113
Gil J, Miralpeix M, Carreras J, Bartrons R (1988) J Biol Chem 263: 1868
Blondel O, Simon J, Chevalier B, Portha B (1990) Am J Physiol 258: E459
Valera A, Rodriguez-Gil JE, Bosch F (1993) J Clin Invest 92: 4
Saxena AK, Srivastava P, Baquer NZ (1992) Eur J Pharmacol 216: 123
Brichard SM, Desbuquois B, Girard J (1993) Mol Cell Endocrinol 91: 91
Bollen M, Miralpeix M, Ventura F, Toth B, Bartrons R, Stalmans W (1990) Biochem J 267: 269
RossettilL, Laughlin MR (1989) J Clin Invest 84: 892
Reaven GM (1993) Ann Rev Med 44: 121
Blondel’Q, Bailbe D, Portha B (1989) Diabetologia 32: 185
Cordera R, Andraghetti G, DeFronzo RA, Rossetti L (1990) Endocrinology 126: 2177
Pugazhenthi S, Angel JF, Khandelwal RL (1991) Metabolism 40: 941
Brichard SM, Bailey CJ, Henquin J-C (1990) Diabetes 39: 1326
Meyerovitch J, Rothenberg P, Shechter Y, Bonner-Weir S, Kahn CR (1991) J Clin Invest 87: 1286
Brichard SM, Pottier AM, Henquin J-C (1989) Endocrinology 125: 2510
Brichard SM, Ongemba LN, Henquin J-C (1992) Diabetologia 35: 522
Cam MC, Faun J, McNeill JH (1994) Metabolism 44: 332
Pederson RA, Ramanadham S, Buchan AMJ, McNeill JH (1989) Diabetes 38: 1390
Brichard SM, Lederer J, Henquin J-C (1991) Diabetes Metab (Paris) 17: 435
Dai S, Thompson KH, McNeill JH (1994) Pharmacol Toxicol 74: 101
Battell ML, Yuen VG, McNeill JH (1992) Pharmacol Commun 1: 291
Parker RDR, Sharma RP (1978) J Environ Pathol Toxicol 2: 235
Sekar N, Kanthasamy A, Williams S, Subramanian S, Govindasamy S (1990) Pharmacol Res 22: 207
Thompson KH, Leichter J, McNeill JH (1993) Biochem Biophys Res Comm 197: 1549
Srivastava P, Saxena AK, Kale RK, Baquer NZ (1993) Res Comm Chem Path Pharm 80: 283
Cam MC, Pederson RA, Brownsey RW, McNeill JH (1993) Diabetologia 36: 218
Bendayan M, Gingras D (1989) Diabetologia 32: 561
Sakurai H, Tsuchiya K, Nukatsuka M, Kawada J, Ishikawa S, Yoshida H, Komatsu M (1990) J Clin Biochem Nutr 8: 193
McNeill JH, Yuen VG, Dai S, Orvig C (1995) Mol Cell Biochem 153: 175
Posner BI, Shaver A, Fantus IG (1990) Insulin mimetic agents: vanadium and peroxovanadium compounds. In: Bailey CJ, Flatt PR (eds) New antidiabetic drugs. Smith Gordon, London, p 107
McNeill J JH, Yuen VG, Hoveyda HR, Orvig C (1992) J Med Chem 35: 1489
Caravan P, Gelmini L, Glover N, Herring FG, Li H, McNeill JH, Rettig SJ, Setyawati IA, Shuter E, Sun Y, Tracey AS, Yuen VG, Orvig C (1995) J Am Chem Soc 117: 12, 759
Hanson GR, Sun Y, Orvig C (1996) Inorg Chem 35: 6507
Sun Y, James BR, Rettig SJ, Orvig C (1996) Inorg Chem 35: 1667
Yuen VG, Orvig C, McNeill JH (1993) Can J Physiol Pharm 71: 263
Yuen VG, Orvig C, Thompson KH, McNeill JH (1993) Can J Physiol Pharm 71: 270
Yuen VG, Orvig C, McNeill JH (1995) Can J Physiol Pharm 73: 55
Waldron-Edward D (1971) Effects of pH and counter-ion on absorption of metal ions. In: Skoryna SC, Waldron-Edward D (eds) Intestinal absorption of metal ions, trace elements and radionuclides. Pergamon, Toronto, p 373
Orvig C, Thompson KH, Cam MC, McNeill JH (in press) Vanadium compounds as posible insulin modifiers. In: Farrell ND (ed) Uses of inorganic chemistry in medicine. Royal Society of Chemistry, London
Sakurai-H, Fujii K, Watanabe H, Tamura H (1995) Biochem Biophys Res Comm 214: 1095
Melchior M, Thompson KH, Jong JM, Rettig SJ, Shuter E, Yuen VG, Zhou Y, McNeill JH, Orvig C (1999) Inorg Chem 38: 2288
Fujimoto S, Fujii K, Yasui H, Matsushita R, Takada J, Sakurai H (1997) J Clin Biochem Nutr 23: 113
Kawabe K, Tadokoro M, Kojima Y, Fujisawa Y, Sakurai H (1998) Chem Lett 1998: 9
Sakurai H, Taira Z, Sakai N (1988) Inorg Chim Acta 151: 85
Watanabe H, Nakai M, Komazawa K, Sakurai H (1994) J Med Chem 37: 876
Cam MC, Cros GH, Serrano J-J, Lazar R, McNeill JH (1993) Diab Res Clin Practice 20: 111
Shechter Y, Shisheva A, Lazar R, Libman J, Shanzer A (1992) Biochemistry 31: 2063
Czech MP, Lawrence JCJ, Lynn WS (1974) Proc Natl Acad Sci USA 71: 4173
May JM, de Haen C (1979) J Biol Chem 254: 9017
Kadota S, Fantus IG, Deragon G, Guyda HJ, Posner BI (1987) J Biol Chem 262: 8252
Kadota S, Fantus G, Deragon G, Guyda HJ, Hersh B, Posner BI (1987) Biochem Biophys Res Comm 147: 259
Fantus IG, Kadota S, Deragon G, Foster B, Posner BI (1989) Biochemistry 28: 8864
Shisheva A, Shechter Y (1993) Endocrinology 133: 1562
Hadari YR, Geiger B, Nadiv O, Sabanay I, Roberts CTJ, LeRoith D, Zick Y (1993) Mol Cell Endocrinol 97: 9
Shisheva A, Ikonomov O, Shechter Y (1994) Endocrinology 134: 507
Shaver A, Ng JB, Hall DA, Soo Lum B, Posner BI (1993) Inorg Chem 32: 3109
Bevan AP, Drake PG, Yale J-F, Shaver A, Posner BI (1995) Mol Cell Biochem 153: 49
Posner BI, Faure R, Burgess JW, Bevan AP, Lachance D, Zhang-Sun G, Fantus IG, Ng JB, Hall DA, Soo Lum B, Shaver A (1994) J Biol Chem 269: 4596
Eriksson JW, Lönroth P, Posner BI, Shaver A, Wesslau C, Smith UPG (1996) Diabetologia 39: 235
Stearns DM, Armstrong WH (1992) Inorg Chem 31: 5178
Evans GW, Bowman TD (1992) J Inorg Biochem 46: 243
Yale J-F, Lachance D, Bevan AP, Vigeant C, Shaver A, Posner BI (1995) Diabetes 44: 1274
Yale J-F, Vigeant C, Nardolillo C, Chu Q, Yu J-Z, Shaver A, Posner BI (1995) Mol Cell Biochem 153: 181
Yu Z-W, Posner BI, Smith U, Eriksson JW (1996) Biochim Biophys Acta 1310: 103
Yu Z-W, Jansson P-A, Posner BI, Smith U, Eriksson JW (1997) Diabetologia 40: 1197
Djordjevic C, Vuletic N, Reslo ML, Puryear BC, Alimard R (1995) Mol Cell Biochem 153: 25
Krejsa CM, Nadler SG, Esselstyn JM, Kavanagh TJ, Ledbetter JA, Schieven GL (1997) J Biol Chem 272: 11, 541
Crans DC, Keramida AD, Hoover-Litty H, Anderson OP, Miller MM, Lemoine LM, Pleasic- Williams S, Vandenberg M, Rossomoando AJ, Sweet LJ (1997) J Am Chem Soc 119: 5447
Messerschmidt A, Wever R (1996) Proc Natl Acad Sci USA 93: 392
Cornman CR, Geiser-Bush KM, Rowley SR, Boyle PD (1997) Inorg Chem 36: 6401
Bevan AP, Burgess JW, Yale J-F, Drake PG, LaChance D, Baquiran G, Shaver A, Posner BI (1995) Am J Physiol 268: E60
Durai N, Saminathan G (1997) J Clin Biochem Nutr 22: 31
Anderson RA, Brantner JH, Polansky MM (1978) J Agric Food Chem 26: 1219
Band CJ, Posner BI, Dumas V, Contreres J-0 (1997) Mol Endocrinol 11: 1899
Elberg G, Li J, Shechter Y (1994) J Biol Chem 269: 9521
Schieven GL, Wahl AF, Myrdal S, Grosmaire L, Ledbetter JA (1995) J Biol Chem 270: 20, 824
Shechter Y, Meyerovitch J, Gefel D, Bruck R, Shisheva A, Elberg G, Libman J, Shanzer A (1993) Frontiers Endocrinol 1: 51
Liu J, Reuland DJ, Rosenhein L, Cao ZX, Franklin LA, Ganguli S (1997) Metab Clin Exp 46: 565
Yuen VG, Caravan P, Gelmini L, Glover N, McNeill JH, Setyawati IA, Shuter E, Zhou Y, Orvig C (1997) J Inorg Biochem 68: 109
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Thompson, K.H., McNeill, J.H., Orvig, C. (1999). Vanadium-Containing Insulin Biomimetic Drugs. In: Clarke, M.J., Sadler, P.J. (eds) Metallopharmaceuticals II. Topics in Biological Inorganic Chemistry, vol 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60061-6_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-60061-6_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64239-5
Online ISBN: 978-3-642-60061-6
eBook Packages: Springer Book Archive